ArticleBlood advances2021

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma.

Christopher J Forlenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.